Is meningioma from Depo-Provera reversible?

Some smaller meningiomas may stabilize or even shrink after stopping Depo-Provera, but larger or symptomatic tumors typically require surgery, radiation, or both. The reversal potential depends on tumor size, location, and individual biology. This is a medical question that should be directed to a neurosurgeon — not something to wait on without medical evaluation.

Home chevron_right Legal Guides chevron_right Depo-Provera Long-Term Side Effects

Depo-Provera long term side effects showing health risks including bone density loss fertility delays depression and meningioma brain tumor from injectable birth control medroxyprogesterone acetate

Health Research

Depo-Provera Long-Term Side Effects: What Science Says About Bone Loss, Fertility, and Brain Tumors

Q: Does Depo-Provera cause permanent bone loss?

Research shows that Depo-Provera causes significant bone mineral density loss — averaging 5–6% over 2 years of use — by suppressing estrogen. The FDA added a black box warning about this in 2004. Studies suggest bone density largely recovers after stopping, particularly in younger women, but recovery may be incomplete in some long-term users. Women who used Depo-Provera during peak bone-building years (teens and early 20s) may face elevated osteoporosis risk.

Q: How long does it take to get pregnant after stopping Depo-Provera?

Unlike most contraceptives, Depo-Provera does not have an immediate return to fertility. On average, it takes 9–18 months after the last injection to conceive, with some women waiting 2–5 years. The delay is not related to how long you used Depo-Provera — it's a pharmacological feature of the injectable hormone that persists in the body.

5–6%

Avg Bone Density Loss (2 yrs)

9–18 mo

Avg Return to Fertility

5.55x

Meningioma Risk (1+ yr use)

To Check Your Claim

The Short Answer

Depo-Provera's long-term side effects include bone mineral density loss (FDA black box warning since 2004), significant fertility delays after stopping, depression and mood disturbances, weight changes, irregular bleeding, and — discovered more recently — an elevated risk of meningioma brain tumors in women who used it for one or more years.

Rachel T. used Depo-Provera for twelve years, starting when she was 23 and her OB-GYN described it as "the most convenient option." Over those years, she gained weight she couldn't explain, noticed her mood shifting in the week before each injection, and had a bone density scan at 34 that came back lower than expected for her age. She was told it was "probably fine."

Then, at 37, she started experiencing intermittent vision changes and headaches. An MRI revealed a meningioma — a brain tumor along the protective lining of her brain. Her neurologist mentioned that research had linked long-term Depo-Provera use to elevated meningioma risk.

"I had no idea. I knew about the bone thing — it was in some pamphlet I barely read. But a brain tumor? That was never part of the conversation. Not once."

"I got the bone density warning in a pamphlet. The brain tumor risk never came up — not in twelve years of injections." — Composite experience, Depo-Provera long-term user

The Documented Long-Term Side Effects

warning

Bone Mineral Density Loss

FDA Black Box Warning

Depo-Provera suppresses estrogen production, which directly reduces bone mineral density. Studies show an average loss of 5–6% over 2 years of use. The FDA added its strongest warning label — a black box warning — in 2004, advising against use beyond 2 years unless no other option exists. Research suggests density largely recovers after stopping, particularly in younger women, but recovery is not guaranteed and may be incomplete in long-term users.

Disclosed in product label since 2004 — less viable for new failure-to-warn claims.

child_care

Fertility Delay After Stopping

Unlike pills or IUDs, Depo-Provera does not allow for an immediate return to fertility. Average time to conception after the last injection is 9–18 months. Some studies show delays of 2–5 years in a subset of women. This delay is not related to duration of use — even women who received just one injection may experience extended delays. This is a known, labeled effect.

mood_bad

Depression and Mood Disturbances

Multiple studies have found associations between progestogen-only contraceptives and increased rates of depression, particularly in adolescents. Medroxyprogesterone affects serotonin and dopamine pathways in ways that pill-based contraceptives may not. A landmark Danish cohort study of over 1 million women found a statistically significant link between hormonal contraceptive use — including injectable progestins — and depression diagnoses and antidepressant prescriptions.

monitor_weight

Weight Changes

Clinical studies show average weight gain of 5–8 pounds in the first year of Depo-Provera use, with continued gain in subsequent years for some women. The mechanism involves appetite stimulation and changes in fat metabolism driven by medroxyprogesterone. Weight gain tends to be more pronounced in women who were already overweight at the start of use.

water_drop

Irregular Bleeding and Amenorrhea

Most Depo-Provera users experience irregular bleeding, particularly in the first 6–12 months. After 12 months of continuous use, approximately 50% of women stop having periods entirely (amenorrhea). While this is often seen as a benefit, its abrupt onset can cause significant anxiety and it can mask other gynecological conditions that would normally present with menstrual symptoms.

emergency

Meningioma Brain Tumors

Active Litigation

This is the most serious long-term risk and the basis for current litigation against Pfizer. Multiple peer-reviewed studies — including a 2022 French national cohort study and research published in the British Medical Journal — found women who used Depo-Provera for one or more years had up to 5.55 times the meningioma risk of non-users. The FDA required Pfizer to add a meningioma warning to the label in December 2025 — years after the research was available. Courts are examining what Pfizer knew and when it knew it.

The meningioma risk was not disclosed in the original product label — this is the core of the lawsuit.

Depo-Provera long term side effects infographic showing bone density loss fertility delay depression weight changes and meningioma brain tumor risk from injectable contraceptive medroxyprogesterone — The full spectrum of Depo-Provera's documented long-term health effects — and which ones Pfizer disclosed.

Which Side Effects Have Legal Remedies?

Not all Depo-Provera side effects support a lawsuit — the legal question is whether Pfizer warned prescribers and patients adequately. Here's how each breaks down:

Side Effect	In Original Label?	Legal Status
Bone density loss	Yes — Black box since 2004	Disclosed — limited new claims
Fertility delay	Yes — labeled effect	Disclosed — limited new claims
Weight gain	Yes — noted in label	Disclosed — limited new claims
Irregular bleeding	Yes — labeled effect	Disclosed — limited new claims
Meningioma brain tumor	No — added Dec 2025	Active litigation — 3,769+ cases

Science

Does Depo-Provera Cause Brain Tumors? What the Research Shows

Regulatory

FDA Finally Added a Brain Tumor Warning to Depo-Provera in December 2025

Action Guide

Just Diagnosed with a Brain Tumor After Depo-Provera? 30-Day Action Plan

Eligibility

Depo-Provera Lawsuit: Who Qualifies to File a Claim in 2026?

Frequently Asked Questions

Does Depo-Provera cause permanent bone loss?add

Research shows Depo-Provera causes significant bone mineral density loss — averaging 5–6% over 2 years — by suppressing estrogen. The FDA added a black box warning in 2004. Studies suggest bone density largely recovers after stopping, particularly in younger women, but recovery may be incomplete in some long-term users.

How long does it take to get pregnant after stopping Depo-Provera?add

On average, it takes 9–18 months after the last injection to conceive, with some women waiting 2–5 years. The delay is not related to how long you used Depo-Provera — it's a pharmacological feature of the injectable hormone that persists in the body.

Can Depo-Provera cause depression?add

Multiple studies have found associations between progestogen-only contraceptives including Depo-Provera and increased risk of depression, particularly in adolescents and young women. The mechanism involves medroxyprogesterone's effects on serotonin and dopamine pathways.

Is a meningioma from Depo-Provera reversible?add

Some smaller meningiomas may stabilize or shrink after stopping Depo-Provera, but larger or symptomatic tumors typically require surgery, radiation, or both. This is a medical question that should be directed to a neurosurgeon — don't wait without evaluation.

Which Depo-Provera side effects have legal remedies?add

Of the known long-term side effects, meningioma brain tumors are the primary basis for current litigation against Pfizer. The lawsuits argue that Pfizer knew about the meningioma risk years before the FDA required a warning in December 2025, and failed to disclose it. Bone density loss, fertility delay, and mood effects were disclosed in the label, making them less viable for new failure-to-warn claims.

If Your Side Effect Was a Brain Tumor — You May Have a Case

Meningioma is the only Depo-Provera side effect that Pfizer failed to warn about for decades. If you used Depo-Provera for one year or more and were diagnosed with a meningioma, a free consultation can tell you if you qualify.

Check Your Eligibility — Free

$0 upfront · Contingency fee only · Free case evaluation